Myriad Genetics Files 8-K on Officer Changes and Shareholder Votes
Ticker: MYGN · Form: 8-K · Filed: Jun 5, 2025 · CIK: 899923
| Field | Detail |
|---|---|
| Company | Myriad Genetics Inc (MYGN) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, shareholder-vote
Related Tickers: MYGN
TL;DR
MYGN leadership shuffle and votes happening, check the filings.
AI Summary
Myriad Genetics, Inc. filed an 8-K on June 5, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing provides updates on the company's leadership and governance, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing standard board and officer changes, not indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- MYRIAD GENETICS INC (company) — Registrant
- June 5, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 87-0494517 (tax_id) — IRS Employer Identification No.
- 322 North 2200 West Salt Lake City , Utah 84116 (address) — Address of principal executive offices
- 801-584-3600 (phone_number) — Registrant's telephone number
FAQ
What specific items were reported under the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' section?
The filing indicates that these events occurred, but the specific details of departures, elections, appointments, and compensatory arrangements are not provided in this summary section of the 8-K.
What is the significance of the 'Submission of Matters to a Vote of Security Holders' item?
This item signifies that the company presented certain proposals or issues for shareholders to vote on during a meeting or via proxy.
What type of financial information is included in the filing?
The filing states that 'Financial Statements and Exhibits' are included, suggesting that financial data and supporting documents are part of the report.
When was this 8-K report filed with the SEC?
The report was filed on June 5, 2025.
What is Myriad Genetics, Inc.'s primary business classification according to the filing?
Myriad Genetics, Inc. is classified under 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' with the SIC code 2835.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding MYRIAD GENETICS INC (MYGN).